Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Fujian Shengdi Pharmaceutical Co., Ltd.

Home Clinical Trial Sponsors and OrganizationsFujian Shengdi Pharmaceutical Co., Ltd.

Fujian Shengdi Pharmaceutical Co., Ltd.

308 Wengjiao Road, Xiamen, Fujian, China

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

64

17 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

28

43.8%

Phase 2

22

34.4%

Phase 3

14

21.9%

Trial Status Distribution

Active, not recruiting

9

14.1%

Completed

26

40.6%

Not yet recruiting

8

12.5%

Recruiting

21

32.8%

Clinical Trials

Trials sponsored by this organization (64)

A Extension Study to Evaluate the Safety and Efficacy of HRS-7249 in Patients With Hypertriglyceridemia

Not yet recruiting

Sep 2026400 participants

A Single-Dose Pharmacokinetic Study of HRS-4729 Injection in Healthy Participants and Patients With Renal Impairment

Sep 202632 participants

A Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of HRS-4139 in Healthy Participants

Not yet recruiting

Sep 202640 participants

A Study of HRS-4729 Injection and HRS9531 Injection in Participants With Metabolic Dysfunction-Associated Steatohepatitis

Aug 2026160 participants

A Mass Balance Study of [14C]HRS-9057 for Injection in Healthy Participants

Active, not recruiting

Aug 20266 participants

A Clinical Trial of HRS5580 for Injection Combined With Palonosetron Hydrochloride for the Prevention of Postoperative Nausea and Vomiting

Aug 2026260 participants

A Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Tablets in Overweight or Obese Subjects

Jul 2026675 participants

Phase III Study of HRS-5635 in Nucleos(t)Ide Analogue-suppressed HBeAg-negative Patients With Chronic Hepatitis B

Jul 2026540 participants

Page 1 of 8

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials64
Approvals
News

Back to Organizations